CPT code 0071T designates magnetic resonance imaging guided focused ultrasound (MRgFUS) to heat and destroy noncancerous uterine leiomyomata with total volume up to 200 cc. This minimally invasive, image-guided thermal ablation technique is performed with the patient inside an MRI scanner, which provides real-time temperature monitoring and precise targeting. Nationally, the code represents an advanced, device-dependent therapeutic option for symptomatic uterine fibroids that can affect utilization, imaging capacity, and specialty practice patterns.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for MRgFUS, common sites of service, and how the service maps to billing workflows. The publication summarizes benchmark considerations for adoption and utilization, outlines relevant payer coverage patterns where available, and highlights policy and coding updates that influence reimbursement and documentation requirements. Clinical implications for patient selection, procedure setting, and imaging resource needs are discussed to give payers and providers a national perspective on implementation and billing for CPT code 0071T.